Randomized trials of platelet function and genetic testing to guide antiplatelet decisions following PCI have produced notoriously mixed results: now, an updated consensus document aims to fill some ...
The MarketWatch News Department was not involved in the creation of this content. WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the ...
Managing drug dosage is critical to the overall success of pharmaceutical intervention, not only in the clinic but also in clinical trials. Inadequate dose management of certain drugs can have fatal ...
ROME, ITALY — Monitoring platelet function and individualizing antiplatelet therapy did not improve outcomes for elderly ACS patients undergoing coronary stenting, results of the ANTARCTIC trial show ...
WATERTOWN, Mass., April 6, 2026 /PRNewswire/ -- PlateletDiagnostics, LLC (PlateletDx.com) today announced the development of a first-in-class platelet function assay that measures phosphorylation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results